Phanesthera
1 known investors
Phanes Therapeutics is a clinical-stage biotech company developing bispecific antibodies and other biologics for immuno-oncology, with three Phase 2 trials (spevatamig, peluntamig, mavrostobart). It uses proprietary platforms — PACbody, SPECpair, and ATACCbody — to build cancer therapeutics addressing unmet medical needs.
BiotechDeep TechHealthtech